Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update

Go back to Larimar Therapeutics (LRMR) Provides Nomlabofusp Development Update
(NASDAQ: LRMR) Delayed: 3.87 -0.2 (4.91%)
Previous Close $4.07    52 Week High
Open $4.03    52 Week Low
Day High $4.17    P/E N/A 
Day Low $3.83    EPS
Volume 978,796